Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotigotine Nasal Spray for Acute RLS Symptoms
NCT00389831Phase 2Completed
- Sponsor
- UCB
- Start
- Aug 2006
- Primary completion
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in restless legs syndrome (RLS) comparing Placebo with Rotigotine Nasal Spray (2 arms). Primary endpoints: Average Numeric Symptom Severity Score and Periodic Leg Movement Index During Wakefulness. Started Aug 2006; status: completed.
02
Drugs
rotigotine
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT00389831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00389831.